National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/26/2021 release of VAERS data:

This is VAERS ID 1778834

Government Disclaimer on use of this data

Case Details

VAERS ID: 1778834 (history)  
Form: Version 2.0  
Age: 72.0  
Sex: Female  
Location: Michigan  
   Days after vaccination:201
Submitted: 0000-00-00
Entered: 2021-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Unknown       Purchased by: ?
Symptoms: Acute kidney injury, Acute respiratory failure, Agitation, Anticoagulant therapy, Blood lactic acid, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Computerised tomogram thorax abnormal, Confusional state, Dyspnoea, Fatigue, Fibrin D dimer increased, Hypoxia, Intensive care, Lactic acidosis, Lung consolidation, Metabolic function test, Metabolic function test abnormal, Oxygen saturation decreased, Procalcitonin increased, Pyrexia, Respiratory failure, SARS-CoV-2 test positive
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Anaphylactic reaction (broad), Asthma/bronchospasm (broad), Lactic acidosis (narrow), Haemorrhage laboratory terms (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Dementia (broad), Acute central respiratory depression (narrow), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Tumour lysis syndrome (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (narrow), Dehydration (broad), Hypokalaemia (broad), Sepsis (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 12 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: acetaminophen (TYLENOL 8 HOUR) 650 MG extended release tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler fluticasone (FLONASE) 50 MCG/ACT nasal spray Fluticasone-Umeclidin-Vilant (TRELEGY ELLIPTA)
Current Illness:
Preexisting Conditions: A-fib (HCC) heart shock Alcohol abuse Allergic Anemia Anxiety Arthritis Backache Chronic Baker''s cyst of knee Right Cataract Chicken pox Chronic bronchitis, simple Colitis COPD (chronic obstructive pulmonary disease) Coronary artery disease Cough Depression Emphysema lung Fracture COMPRESSION FX T SPINE Fracture of T9 vertebra Newer T9 compression fracture Gall stone GERD (gastroesophageal reflux disease) H/O back injury Heart attack History of adenomatous polyp of colon History of smoking Hx of tear of meniscus of knee joint Right Ileostomy status Inflammatory bowel disease Menopause Morbid obesity Osteoporosis PAD (peripheral artery disease) Pneumonia Poor circulation RLS (restless legs syndrome) Shortness of breath at rest Tubular adenoma of colon UC (ulcerative colitis) Vitamin B12 deficiency
Allergies: Prednisone, Reclast, Lialda, Lipitor, Pravastatin, Tudorza Pressair, Diphenhydramine
Diagnostic Lab Data:
CDC Split Type:

Write-up: Hospitalized 09/30/2021; COVID-19 positive 09/30/2021; fully vaccinated Patient is a 72-year-old female presents the chief complaint of fever, fatigue, shortness of breath. Upon initial evaluation she is hypoxic to 86%. Placed on 2 L nasal cannula with good response. COVID-19 testing is positive. She has an AKI evident on CMP. Lactic acid slightly elevated 2.2. She is given 2 L IV fluids for her AKI and lactic acidosis. She does not have a history of decreased EF. Chest x-ray is consistent with COVID-19 pneumonia. She is given 6 mg IV Decadron. I spoke with the hospitalist who agrees to admission and further management of this patient. Assessment/Plan DIAGNOSIS at time of disposition: 1. Pneumonia due to COVID-19 virus 2. Hypoxia 3. Respiratory insufficiency 4. AKI (acute kidney injury) 5. Lactic acidosis 10/3/2021 note: ASSESSMENT / PLAN: Pneumonia due to COVID-19 virus Assessment & Plan Continue remdesivir, inhaled steroid, inhaled beta stimulant, inhaled Spiriva, supplemental oxygen, empirical antibiotic coverage as well given the presence of elevated procalcitonin. She received dexamethasone on hospital day 1 when she was still in ER and then she became confused and agitated, she threatened to leave AMA on hospital day 2 at 7a.m., she was agitated. She did calm down subsequently and I have found out that she does tolerate small amounts of inhaled steroids but not oral steroids. Therefore I switched to the available in the hospital equivalent of Trelegy she takes as an outpatient specifically Dulera and Spiriva plus p.r.n. albuterol. Vitamin C, zinc are also being given. DVT prophylaxis Acute respiratory failure with hypoxia Assessment & Plan Continue high-flow nasal cannula oxygen, she is saturating 93 up to 95% on 60 L, plus non-rebreather, FiO2 is 100%. If she worsens then next step would be intubation 10/8/2021 note: Assessment/Plan: Pneumonia due to COVID-19 virus Assessment & Plan Will continue with present medical regimen. Will give a dose of Lasix today 10/05/2021 will give dose of Lasix today. Also talked her about the steroid issue. She wants to try it again. I thought I had given to her orally my diet have the same subjective feelings that she has been getting with the IV steroids 10/06/2021 her D-dimers markedly elevated at 11,000 thousand. I have empirically started her on heparin drip. Will send her down for a CT angiogram. Will also schedule her for upper lower extremity Dopplers. Clinically she says she feels better today than she did yesterday. 10/07/2021 initially she had an elevated procalcitonin question of an infiltrate. Procalcitonin has normalized but there is consolidation at the mention on her CT scan. I decided to continue broad-spectrum antibiotics for now. In light of her declining respiratory status will move her to the intensive care unit 10/08/2021 she finished remdesivir, she is refusing the empirical antibiotic coverage. Will check a procalcitonin in the morning. She is on the inhaled steroid but she refused the intravenous Solu-Medrol. 10/08/2021 the patient stated to me and also she stated in no uncertain terms to the previous physician that she does not desire intubation in case that she deteriorates to that point. I do intend to honor this and she is therefore a do not resuscitate. However it should be noted that she is now maxed out on nasal cannula high-flow oxygen plus non-rebreather and she is saturating marginally in the low 90s at best. I made her daughter aware of these and I also discussed extensively with the daughter when the that the prognosis is guarded in this patient with COVID pneumonia and pre-existing severe chronic obstructive pulmonary disease. Note from 10/11/2021: 10/09/2021 the patient is saturating marginally on 60 L of oxygen per nasal cannula plus non-rebreather however now she is pleasant and cooperative with the medication therefore this is a bit plus compared to yesterday 10/10/2021 the patient is doing a bit better oxygen saturation wise on the same supplemental oxygen she was on yesterday. She is conversational and speaks in longer sentences before being short of breath. She refused the Lovenox therapeutic but she is okay with the heparin drip. Afebrile. 10/11/2021 I consulted virtual intensive care unit, I appreciated very much their input, the patient is not a candidate for intubation given her chronic obstructive pulmonary disease history. She in fact refused intubation as a concept this morning but then she reconsidered that however after discussing with the pulmonologist the patient again admitted to not wanting intubation and this is in fact inappropriate decision given the advanced emphysema that the patient is suffering from. Noted 30% of predicted DLCO 2 years ago. Noted persistent oxygen needs of 100% via high-flow nasal cannula 70 liters/minute. Noted marginal saturation. As per pulmonologist''s recommendation will decrease the steroids to twice daily. She is off antibiotics since she completed course. Right now I have her on heparin drip, twice daily steroids, supplemental oxygen. Prognosis is guarded.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166